3 stories tagged #Boehringer Ingelheim

  1. Pharma Giants Invest £450M in UK, Boosting Innovation
    health

    Pharma Giants Invest £450M in UK, Boosting Innovation

    AstraZeneca and Boehringer Ingelheim commit significant funds to UK expansion, focusing on research, AI, and new medicines.

    last mo. 1 min read
  2. Boehringer Ingelheim Obesity Drug Shows Significant Weight Loss in Phase 3 Trial
    health

    Boehringer Ingelheim Obesity Drug Shows Significant Weight Loss in Phase 3 Trial

    Boehringer Ingelheim's investigational obesity therapy, survodutide, achieved up to 16.6% average weight loss in a Phase 3 trial, targeting appetite and liver metabolism.

    last mo. 1 min read
  3. Boehringer Ingelheim Releases Critical Insights on HER2 Mutations for Professionals
    health

    Boehringer Ingelheim Releases Critical Insights on HER2 Mutations for Professionals

    New educational resource outlines HER2 mutation impacts on receptor signaling and oncogenesis for US healthcare practitioners.

    2mo ago 1 min read